Webinar Overview
Are you doing everything you can to de-risk your antibody candidates? What does it take to go to preclinical development with a high degree of confidence?
View this webinar to follow the journey of an antibody ‘candidate hero’ as it progresses through the early discovery gauntlet. Together, we will examine and understand:
- The potential of sequencing novel lead selection technologies
- How lead selection innovation in discovery can help manage the risk of later stage attrition
- How advanced candidate selection methods can resonate throughout the entire therapeutic development pipeline
Webinar Presenters
Edward McGowan, MSc, PhD
Director of Advanced Modalities
Charles River
Shahrad Daraeikia, BSc, P.S.M.
Senior Client Manager
Charles River
Nick Brown, MSc
Group Leader, Client Services
Charles River
Namrata Jayanth, PhD
Research Leader
Charles River
Additional Information
- Antibody Discovery and Antibody Engineering
- Identify Primary Receptors and Off-Targets with the Retrogenix® Platform
- Pre-Defined and Custom Assay Development
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.